Creative Realities Inc (CREX)
Official siteTECHNOLOGY • SOFTWARE - APPLICATION • NASDAQ
Market Cap: $27.26M
Last updated: Nov 17, 2026 at 4:18 PM ET
Creative Realities Inc (CREX) Stock Chart
Creative Realities (CREX) has a latest price of $1.95 on Nov 17, 2026, 55.9% below its 52-week high of $4.42. Its price fell 26.1% over the past 12 months. The month-end price fell 89.3% over the 10 years through Oct 2026, a compound annual decline of 20.0%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $38.74 in Jul 2017 and its lowest $1.55 in Sep 2023, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart CREX with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CREX.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 31.3%, and over 6 months it fell 47.6%. The month-end price rose 13.3% over the 3 years through Oct 2026, a compound annual rate of 4.2%.
| Period | Change |
|---|---|
| 1 month | -7.1% |
| 3 months | -31.3% |
| 6 months | -47.6% |
| 12 months | -26.1% |
| 12 months, with dividends | -26.1% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +13.3% | +4.2% |
| 5 years | -53.6% | -14.2% |
| 10 years | -89.3% | -20.0% |
Price by Year
Its best calendar year was 2023, when the price rose 35.6%, and its weakest was 2018, when it fell 76.3%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $2.13 | -18.4% |
| 2025 | $2.61 | +6.5% |
| 2024 | $2.45 | +3.8% |
| 2023 | $2.36 | +35.6% |
| 2022 | $1.74 | -58.6% |
| 2021 | $4.20 | +8.5% |
| 2020 | $3.87 | -15.7% |
| 2019 | $4.59 | -32.9% |
| 2018 | $6.84 | -76.3% |
| 2017 | $28.83 | +3.2% |
Trading Range
The price is 16.4% below its 50-day average of $2.33 and 39.2% below its 200-day average of $3.21.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $1.95 | |
| 52-week high | $4.42 | -55.9% |
| 52-week low | $1.62 | +20.4% |
| 50-day average | $2.33 | -16.4% |
| 200-day average | $3.21 | -39.2% |
Price Risk
Over 3 years, its largest fall from a peak was 74.5%.
| Measure | Value |
|---|---|
| 1-year beta | 1.20 |
| Largest fall, 1 year | -57.6% |
| Largest fall, 3 years | -74.5% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About CREX
What is CREX's 1-year price change?
Creative Realities's price fell 26.1% over the past 12 months. With dividends included, the 12-month total return was -26.1%.
What is CREX's 5-year price change?
Creative Realities's month-end price fell 53.6% over the 5 years through Oct 2026, a compound annual decline of 14.2%. These figures leave out dividends.
What is CREX's 52-week high and low?
Creative Realities's 52-week high is $4.42 and its 52-week low is $1.62. Its latest price of $1.95 on Nov 17, 2026 is 55.9% below the high.
What is CREX's beta?
Creative Realities's 1-year beta against the S&P 500 is 1.20, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 57.6%.
Is the CREX chart free?
Yes. Advanced Charting for CREX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
CREX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors